π End of Day Bhavcopy
Date: 2025-09-09
Price: 710.05
% Change: 0.36% (Prev Close: 707.50)
Volume: 88,440
% Change: 20.73% (Prev Volume: 73,253)
Delivery: 57,188
Delivery % : 64.66
% Change: 27.71% (Prev Delivery: 44,780)
Turnover: 627 Lacs
% Change: 21.14% (Prev Turnover: 518)
πΉ EOD Valuation
P/E Ratio: 42.26
P/B Ratio: 2.84
Market Cap: 3600 Rs. Cr.
Fundamental Data
Date: 05-09-2025
π·οΈ Company Basics
Symbol: ORCHPHARMA
Market Cap: 3723 Rs. Cr.
Face Value: 10.00 Rs.
52 Week High: 1998.00
52 Week Low: 603.80
All-Time High: 2680.00 Rs.
All-Time Low: 3.00 Rs.
Stock Price Increase (% Return) %
% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-6.31% | 3.00% | -23.51% | -46.58% | 32.95%
π₯ Shareholding Pattern
Promoter Holding
Promoter Holding: 69.84%
Change (3Y | 1Y): -20.12% | 0.00%
Pledged %: 0.00%
FII Holding
FII Holding: 1.39%
Change (3Y | 1Y): -0.09% | -1.30%
DII Holding
DII Holding: 19.43%
Change (3Y | 1Y): 16.46% | -0.67%
Public Holding: 9.34%
π¦ Financial Strength
Debt to Equity: 0.14
Debt: 174.61 Rs. Cr.
Book Value: 249.86 Rs.
Current Ratio: 2.83
Interest Coverage: 6.67
Free Cash Flow: -130.89 Rs. Cr.
π Growth & Sales
Sales Growth: -3.45%
Sales Growth Qtr (YOY | QoQ):
-29.25% | -27.18%
Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
13.76% | 18.11% | -3.45%
π° Profit & Earnings
Profit Growth %
Profit Growth: -23.60%
Profit Growth Qtr (YOY | QoQ):
-49.20% | -33.11%
Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
22.51% | 249.01% | -23.60%
EPS Rs.
EPS (TTM): 16.80 Rs.
EPS Qtr (Last Year | Latest):
5.79 Rs. | 2.94 Rs.
EPS Annual (Last Annual | Annual March):
18.17 Rs. | 19.65 Rs.
EPS Growth Variation % (5 Yrs | 3 Yrs):
21.17% | 225.86%
Net Profit Rs. Cr.
Net Profit (TTM): 85.22 Rs. Cr.
Net Profit (Annual - March): 99.66 Rs. Cr.
Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
29.35| 22.29 | 14.91
EBITDA Rs. Cr.
EBITDA (Quarter): 25.63 Rs. Cr.
EBITDA (Previous Yr Ql): 40.06 Rs. Cr.
EBITDA (Annual - March): 144.65 Rs. Cr.
EBITDA (Previous Annual): 142.11 Rs. Cr.
EBITDA (5 Yrs | 3 Yrs) %:
86.67% | 31.87%
π Profitability Ratios
Operating Margin (OPM)
OPM (TTM): 11.63%
OPM Qtr (Previous | Current):
11.79% | 8.20%
OPM Annual (5 Yrs | Last Yr | March):
11.62% | 13.58% | 12.71%
Return on Equity %
ROE: 8.18%
ROE (5 Yrs | 3 Yrs | Last Yr):
1.86% | 7.04% | 9.94%
Return on Capital Employed %
ROCE: 8.02%
ROCE (5 Yrs | 3 Yrs | Last Yr):
2.91% | 7.45% | 9.37%
Return on Assets %
ROA (TTM): 6.15%
ROA (5 Yrs | 3 Yrs | Last Yr):
0.87% | 4.45% | 6.65%
PEG Ratio: 0.18
Dividend Yield: 0.00%
PE 3 Yrs: 59.44
PE 5 Yrs: 59.44
Dividend Yield: 0.00%
π₯ Company
Orchid Pharma Ltd
ORCHPHARMA
Promoter Holding: %